Literature DB >> 18056386

West Nile virus envelope protein inhibits dsRNA-induced innate immune responses.

Alvaro Arjona1, Michel Ledizet, Karen Anthony, Nathalie Bonafé, Yorgo Modis, Terrence Town, Erol Fikrig.   

Abstract

The immune response against viral infection relies on the early production of cytokines that induce an antiviral state and trigger the activation of immune cells. This response is initiated by the recognition of virus-associated molecular patterns such as dsRNA, a viral replication intermediate recognized by TLR3 and certain RNA helicases. Infection with West Nile virus (WNV) can lead to lethal encephalitis in susceptible individuals and constitutes an emerging health threat. In this study, we report that WNV envelope protein (WNV-E) specifically blocks the production of antiviral and proinflammatory cytokines induced by dsRNA in murine macrophages. This immunosuppressive effect was not dependent on TLR3 or its adaptor molecule Trif. Instead, our experiments show that WNV-E acts at the level of receptor-interacting protein 1. Our results also indicate that WNV-E requires a certain glycosylation pattern, specifically that of dipteran cells, to inhibit dsRNA-induced cytokine production. In conclusion, these data show that the major structural protein of WNV impairs the innate immune response and suggest that WNV exploits differential vector/host E glycosylation profiles to evade antiviral mechanisms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18056386     DOI: 10.4049/jimmunol.179.12.8403

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

Review 1.  Recent insights into the role of Toll-like receptors in viral infection.

Authors:  M Carty; A G Bowie
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

Review 2.  The mechanism of necroptosis in normal and cancer cells.

Authors:  Simone Fulda
Journal:  Cancer Biol Ther       Date:  2013-09-12       Impact factor: 4.742

Review 3.  Biochemistry and Molecular Biology of Flaviviruses.

Authors:  Nicholas J Barrows; Rafael K Campos; Kuo-Chieh Liao; K Reddisiva Prasanth; Ruben Soto-Acosta; Shih-Chia Yeh; Geraldine Schott-Lerner; Julien Pompon; October M Sessions; Shelton S Bradrick; Mariano A Garcia-Blanco
Journal:  Chem Rev       Date:  2018-04-13       Impact factor: 60.622

Review 4.  The 'ubiquitous' reality of vector immunology.

Authors:  Maiara S Severo; Olivia S Sakhon; Anthony Choy; Kimberly D Stephens; Joao H F Pedra
Journal:  Cell Microbiol       Date:  2013-03-14       Impact factor: 3.715

Review 5.  Toll-like receptors: key players in antiviral immunity.

Authors:  Nicholas Arpaia; Gregory M Barton
Journal:  Curr Opin Virol       Date:  2011-10-28       Impact factor: 7.090

6.  West Nile virus noncoding subgenomic RNA contributes to viral evasion of the type I interferon-mediated antiviral response.

Authors:  Andrea Schuessler; Anneke Funk; Helen M Lazear; Daphne A Cooper; Shessy Torres; Stephane Daffis; Babal Kant Jha; Yutaro Kumagai; Osamu Takeuchi; Paul Hertzog; Robert Silverman; Shizuo Akira; David J Barton; Michael S Diamond; Alexander A Khromykh
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

7.  West nile virus: characteristics of an african virus adapting to the third millennium world.

Authors:  Marina Monini; Emiliana Falcone; Luca Busani; Roberto Romi; Franco Maria Ruggeri
Journal:  Open Virol J       Date:  2010-04-22

Review 8.  Immunomodulatory effects of dsRNA and its potential as vaccine adjuvant.

Authors:  Bo Jin; Tao Sun; Xiao-Hong Yu; Chao-Qun Liu; Ying-Xiang Yang; Ping Lu; Shan-Feng Fu; Hui-Bin Qiu; Anthony E T Yeo
Journal:  J Biomed Biotechnol       Date:  2010-07-05

9.  Ross River virus envelope glycans contribute to type I interferon production in myeloid dendritic cells.

Authors:  Reed S Shabman; Kristin M Rogers; Mark T Heise
Journal:  J Virol       Date:  2008-10-15       Impact factor: 5.103

10.  Reversal of West Nile virus-induced blood-brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor.

Authors:  Saguna Verma; Mukesh Kumar; Ulziijargal Gurjav; Stephanie Lum; Vivek R Nerurkar
Journal:  Virology       Date:  2009-11-18       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.